| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Hypoxia-inducible factor 1-alpha|HIF-1-alpha|HIF1-alpha|ARNT-interacting protein|Basic-helix-loop-helix-PAS protein MOP1|Class E basic helix-loop-helix protein 78|bHLHe78|Member of PAS protein 1|PAS domain-containing protein 8|HIF1A|BHLHE78|MOP1|PASD8 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human HIF1A (Hypoxia-inducible factor 1-alpha) is a molecular target commonly studied in signal transduction, neuroscience, and cardiovascular research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of HIF1A is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of HIF1A can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
HIF1A (Hypoxia-inducible factor 1-alpha) may also be referenced as Hypoxia-inducible factor 1-alpha, HIF-1-alpha, and HIF1-alpha in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how HIF1A relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in signal transduction, neuroscience, and cardiovascular research.
- Interpreting shifts in HIF1A levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
HIF1A has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with signal transduction, neuroscience, and cardiovascular studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
On-Chip Organoid Formation to Study CXCR4/CXCL-12 Chemokine Microenvironment Responses for Renal Cancer Drug Testing
IF: 5.743 Journal: Biosensors Cited Date: 2022-12-23
Human Dental Pulp Mesenchymal Stem Cell-Derived Soluble Factors Combined with a Nanostructured Scaffold Support the Generation of a Vascular Network In Vivo
IF: 5.3 Journal: Nanomaterials Author: Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy Cited Date: 2023-09-08
Sestrin-2 and hypoxia-?nducible factor-1 alpha levels in major depressive disorder and its subtypes
IF: 4.415 Journal: Psychopharmacology Author: Department of Psychiatry, Aksaray Training and Research Hospital, Aksaray, Turkey Cited Date: 2023-06-16
Molecular biological investigation of temozolomide and KC7F2 combination in U87MG glioma cell line
IF: 2.984 Journal: Gene Cited Date: 2021-07-01
Radiation and chemotherapy variable response induced by tumor cell hypoxia: impact of radiation dose, anticancer drug, and type of cancer
IF: 1.925 Journal: Radiation and Environmental Biophysics Cited Date: 2022-04-14
Serum HIF-1α, IGF-1 and IGFBP-3 correlate to recurrence and overall survival in early-stage hepatocellular carcinoma patients
IF: 1.9 Journal: Biomarkers in Medicine Author: Department of Ultrasonography, Wuxi People's Hospital Affiliated to Nanjing Medical University, Qingyang Road, Wuxi, 214023, Jiangsu, China. Cited Date: 2024-11-29
Involvement of Perk and ATF6 Signal Pathways in Indicating Unfolded Protein Response in Patients with Chronic Lymphocytic Leukaemia
IF: 1.9 Journal: Biomarkers Author: Department of Hematology, Faculty of Medicine, Karadeniz Technical University. Cited Date: 2025-09-05
Differences in the Blood Levels of HIF-1α and VNN1 and Expression of HIF1A and NFKB1 in Leukocytes in Cardiological Patients with Risk of Postoperative Complications
IF: 0.6 Journal: Bulletin of Experimental Biology and Medicine Author: Petrovsky National Research Centre of Surgery, Moscow, Russia. Cited Date: 2025-07-25
Determination of the Risk of Tumor Progression in Patients with Early Stages of Adenocarcinoma and Squamous Cell Lung Carcinoma Based on Laboratory Parameters
IF: 0.463 Journal: Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry Cited Date: 2022-06-03
HIF-1α, CD44v6 and Hyaluronic Acid are Potential Biomarkers of Non-small Cell Lung Cancer
IF: Journal: DSpace Repository Cited Date: 2022-04-01